Careers Contact

Evaxion > Investors > Events & presentations

Events & presentations

Here you can find our upcoming and past events, and presentations.

Upcoming events & presentations

Business update and full year 2025 financial results

Evaxion will provide a business update and report its full year 2025 financial results on Thursday, March 5, 2026, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. This event is free, open to the public and encouraged.

Mar 11 – Mar 14, 2026

Shanghai, China

Vaccine Innovation Forum World 2026

VIF World 2026, the Vaccine Innovation Forum, stands as a premier international event dedicated to the advancement of vaccine science and global health. Building on the tremendous success of previous forums in Shanghai, this year’s conference aims to further cement its reputation as a crucial meeting place for global experts, researchers, policymakers, and industry leaders. […]

Mar 24 – Mar 25, 2026

London, United Kingdom

Nextgen Biomed 2026- Immunotherapy & Vaccines (Oxford Global)

A carefully curated event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of novel immunotherapies; advances in cellular, antibody and combination therapy development, as well as personalised cancer therapy treatments.

Annual General Meeting

The board of directors hereby convenes the annual general meeting of Evaxion A/S, company registration (CVR) no. 31 76 28 63 (the "Company"), to be held on 16 April 2026 at Evaxion A/S, Dr Neergaards Vej 5F, 2970 Hørsholm, Denmark.

Business update and first quarter 2026 financial results

Evaxion will provide a business update and report its first quarter 2026 financial results on Thursday, May 7, 2026, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. This event is free, open to the public and encouraged.

Business update and second quarter 2026 financial results

Evaxion will provide a business update and report its third quarter 2025 financial results on Thursday, August 20, 2026, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. This event is free, open to the public and encouraged.

Previous events & presentations

Jan 12 – Jan 15, 2026

San Francisco, United States

18th Biotech Showcase

Coinciding with the 44th annual J.P. Morgan Healthcare Conference, Biotech Showcase takes place on January 12-14, 2026 in San Francisco, CA. It is a leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives.

Sidoti Year End Virtual Investor Conference

CFO Thomas Schmidt will present our AI-Immunology™ platform, pipeline and strategy at the virtual Sidoti Year End Conference on Thu, Dec 11 at 8:30AM ET/14:30 CET.

Dec 6 – Dec 9, 2025

Orlando, United States

67th ASH Annual Meeting

With hundreds of sessions, thousands of abstracts, and countless ways to experience the best in hematology, the ASH annual meeting is the world's premier global hematology event.

Nov 18 – Nov 20, 2025

Boston, United States

2nd Personalized Cancer Vaccines Summit

The 2nd Annual Personalized Cancer Vaccine Summit returns to Boston as the only strategic forum dedicated to platforming the full spectrum of individualized cancer vaccines. With granular insights from early discovery and preclinical efforts through to the optimization of clinical and manufacturing strategies. Join 80+ CXOs, VPs, and Directors of Oncology, Immunotherapy, and Vaccine R&D […]

Nov 13 – Nov 14, 2025

London, United Kingdom

NextGen Omics & Data 2025

Bringing together 1000+ key scientific researchers, pharma representatives, & healthcare leaders under one roof to accelerate omics research across therapeutic areas through our NGS & Clinical Diagnostics; Multi-Omics in Single Cell and Spatial Analysis; NextGen Omics Data & Analysis; & Liquid Biopsies programmes.

Business update and third quarter 2025 financial results

Evaxion will provide a business update and report its third quarter 2025 financial results on Friday October 31, 2025, before opening of the Nasdaq CM.

Corporate presentation